ID: MRFR/MED/1882-CR | February 2021 | Region: Global | 104 pages
Global Saliva Collection and Diagnostic Market is expected to register a CAGR of 11.17% during the assessment period of 2020 to 2027, to reach USD 5,470.08 Million by 2027.
The increasing number of product approvals for saliva collection and diagnostic devices is due to the growing need for rapid diagnosis of life-threatening diseases. For example, in January 2015, DNA Genotek, a subsidiary of OraSure Technologies, Inc., received approval from the US Food and Drug Administration (USFDA) for genetic Oragene Dx saliva collection test kits. The saliva collected using these kits is used to screen for Bloom Syndrome, which is a genetic disorder. 23andMe, Inc. works with DNA Genotek to manufacture a genetic Oragene Dx saliva collection test kit. In February 2015, the USFDA approved the proposal of 23andMe, Inc. to market genetic Oragene Dx saliva collection test kits. Additionally, in January 2020, DNA Genotek announced FDA General Use Clearance for Oragene family of products. Oragene Dx are intended for use in the non-invasive collection of saliva samples for in vitro diagnostic testing of human DNA. The growing demand for salivary diagnostics has encouraged number of companies to invest in the market and develop products, kits, and devices for saliva collection and testing. This has resulted in an upsurge in the demand for saliva collection and diagnostics globally.
Global Saliva Collection and Diagnostic Market, by Site of Collection, 2019 (%)
Source: MRFR Analysis
Global Saliva Collection and Diagnostic Market is segmented based on site of Collection, Application, and End User.
The global saliva collection and diagnostic market based on the site of collection has been segmented into parotid gland collection, submandibular/sublingual gland collection, minor salivary glands collection, and others. Parotid gland collection dominated the market in 2019. The market growth is attributed to the feature such as parotid gland collection is one of the widely used collections in diagnosis of inflammatory disease. The global saliva collection and diagnostic market, by application, has been segmented into disease diagnosis, forensics, pharmaceutical and biotechnology companies, and others. The disease diagnosis segment held the largest market share. Increasing geriatric population suffering from various types of chronic disease such as cancer is fueling the growth of this segment. The global saliva collection and diagnostic market, by end user, has been segmented into hospitals & dental clinics, diagnostic centers, investigation laboratories, and others. The hospitals & dental clinics segment dominated the market in 2019. Increasing patient pool in the hospitals raising the demand for saliva collection for diagnosis of disease is propelling the growth of this segment. The hospitals & dental clinics segment held the largest share at a CAGR of 10.73% during the study period.
Western Europe Saliva Collection and Diagnostic Market Share, by Country, 2019 (%)
Source: MRFR Analysis
Global Saliva Collection and Diagnostic Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The Americas spearheaded the market in 2019 and is likely to continue to command during the assessment period. This is attributed to the technological advancements in devices used for disease testing and the rising prevalence of chronic diseases.
The European saliva collection and diagnostic market has been divided into Western Europe and Eastern Europe. The Western Europe saliva collection and diagnostic market has further been classified into Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. Europe would follow the Americas in terms of value during the forecast period owing to the presence of favorable government initiatives, a large target population base, and a rising prevalence of cancer.
The saliva collection and diagnostic market in Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia-Pacific. Asia-Pacific is expected to witness the highest growth potential during the forecast period due to increasing per capita health spending, the developing the healthcare sector in China, India, and Australia, growing demand for saliva collection and diagnostic for respiratory procedures, and the growing geriatric population suffering from various disease.
The Middle East & Africa Saliva collection and diagnostic market is segmented into the Middle East and Africa. The increasing number of healthcare investments is anticipated to drive the market growth in this region.
The prominent players in the global saliva collection and diagnostic market are Neogen Corporation. (US)., SARSTEDT AG & Co. KG (Germany), Quest Diagnostics (US), OraSure Technologies (US), and Abbott Laboratories (US), and others.
Some of the key strategies followed by players operating in the global saliva collection and diagnostic Market were FDA approvals, joint ventures, acquisitions, expansions, and collaborations.
Global Saliva Collection and Diagnostic Market, By Site of Collection
Global Saliva Collection and Diagnostic Market, By Application
Global Saliva Collection and Diagnostic Market, By End User
Global Saliva Collection and Diagnostic Market, By Region
Available Additional Customizations
|Market Size||USD 5,470.08 Million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Collection, Application and End User|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Neogen Corporation. (US)., SARSTEDT AG & Co. KG (Germany), Quest Diagnostics (US), OraSure Technologies (US), and Abbott Laboratories (US)|
|Key Market Opportunities||Saliva-based poct devices|
|Key Market Drivers||
Frequently Asked Questions (FAQ) :
The projected CAGR would be 11.17% during the forecast period.
The market valuation of USD 5,470.08 Million by 2027.
The valuation was USD 1,633.5 million.
The largest segment was biotechnology in 2017.
The biotechnology valuation was USD 878.5 million.